Spots Global Cancer Trial Database for Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer
Official Title: A Randomized Phase III Trial of Postoperative Chemotherapy or Chemo-radiotherapy for Locally Advanced Gastric Cancer After D2 Resection
Study ID: NCT03601988
Conditions
Study Description
Brief Summary: The purpose of this study is to explore the efficacy of adjuvant radiotherapy for D2 resected gastric cancer
Detailed Description: The radiotherapy dose of 45Gy in 25 fractions as adjuvant treatment after D2 surgery for gastric cancer
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact Details
Name: Xianglin Yuan, MD,PhD
Affiliation: Tongji Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
